Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FGLYN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,992
Award facts
- Contract value 100% obligated
- $18,992.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,992.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg dose in 2 pen/mL format, with an ultimate completion date of October 20, 2025. This non-set-aside award, issued on October 17, 2025, represents a single delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen Drug Corp's established capability to meet federal procurement requirements through competitive acquisition and supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications and critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FGLYN?
SPE2DB26FGLYN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FGLYN worth?
The government has obligated $18,992 on SPE2DB26FGLYN.
Is contract SPE2DB26FGLYN an order under another contract?
Yes. SPE2DB26FGLYN is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB26FGLYN competed?
The extent of competition for SPE2DB26FGLYN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award